Covid-19: Covaxin's Trial on Children Between 2-18 Years to Begin in 10-12 Days, Says Govt
The government said on Tuesday trials on Covaxin's efficacy against coronavirus on children between 2-18 years of age to begin in 10-12 days. Addressing a Health Ministry briefing, Niti Aayog member VK Paul said COVAXIN has been approved by the Drugs Controller General of India (DCGI) for phase II and III clinical trials in the age group of 2 to 18 years. 'I have been told that trials will begin in the next 10-12 days," Dr Paul said.
Covaxin, produced by Hyderabad-based Bharat Biotech and is backed by the Indian Council of Medical Research (ICMR), has been found to effective against most of the new strains of the virus that has wreaked havoc in India in its second wave.
Read all the latest updates on COVID-19 here.